Bisphenol A, bisphenol F and bisphenol S affect differently 5α-reductase expression and dopamine-serotonin systems in the prefrontal cortex of juvenile female rats

Environmental Research

Volumn 142, Issue , 2015, Pages 281-287

  Castro, Beatriz ^a   Sánchez, Pilar ^a   Torres, Jesús M ^a   Ortega, Esperanza ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

5 reductase; Bisphenol A; BPA analogs; Dopamine; Serotonin

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BISPHENOL F; BISPHENOL S; CORTICOSTEROID; DOPAMINE; MESSENGER RNA; PHENOL DERIVATIVE; SEROTONIN; STEROID 5ALPHA REDUCTASE; UNCLASSIFIED DRUG; 2,4'-BISPHENOL F; BENZHYDRYL DERIVATIVE; BIS(4-HYDROXYPHENYL)SULFONE; CHOLESTENONE 5ALPHA REDUCTASE; ISOENZYME; SULFONE;

ALCOHOL; AMINO ACID; BRAIN; CHEMICAL ANALYSIS; ENDOCRINE DISRUPTOR; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HORMONE; JUVENILE; POLLUTION EXPOSURE; PREGNANCY; RODENT; STEROID; TOXICITY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYP2D4 GENE; DOPAMINERGIC SYSTEM; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GESTATIONAL AGE; JUVENILE; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTONINERGIC SYSTEM; STEROIDOGENESIS; WESTERN BLOTTING; WISTAR RAT; ANIMAL; DRUG EFFECTS; GENETICS; METABOLISM;

MAMMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; BENZHYDRYL COMPOUNDS; CHOLESTENONE 5 ALPHA-REDUCTASE; DOPAMINE; FEMALE; GENE EXPRESSION; ISOENZYMES; PHENOLS; PREFRONTAL CORTEX; RATS, WISTAR; RNA, MESSENGER; SEROTONIN; SULFONES;

EID: 84938095123     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2015.07.001     Document Type: Article

References (60)

1. Altomare G., Capella G.L. Depression circumstantially related to the administration of finasteride for androgenetic alopecia. J. Dermatol. 2002, 29:665-669.
2. Bäckman L., Karlsson S., Fischer H., Karlsson P., Brehmer Y., Rieckmann A., MacDonald S.W., Farde L., Nyberg L. Dopamine D(1) receptors and age differences in brain activation during working memory. Neurobiol. Aging 2011, 32:1849-1856.
3. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 1995, 57:289-300.
4. Brambilla P., Perez J., Barale F., Schettini G., Soares J.C. GABAergic dysfunction in mood disorders. Mol. Psychiatry 2003, 8(721-737):715.
5. Braun J.M., Kalkbrennerm A.E., Calafatm A.M., Yolton K., Ye X., Dietrich K.N., Lanphear B.P. Impact of early-life bisphenol A exposure on behavior and executive function in children. Pediatrics 2011, 128:873-882.
6. Braun J.M., Yolton K., Dietrich K.N., Hornung R., Ye X., Calafat A.M., Lanphear B.P. Prenatal bisphenol A exposure and early childhood behavior. Environ. Health Perspect. 2009, 117:1945-1952.
7. Bromek E., Haduch A., Daniel W.A. The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: an in vitro study. Eur. J. Pharmacol. 2010, 626:171-178.
8. Brown J.S. Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine disruption theory of schizophrenia. Schizophr. Bull. 2009, 35:256-278.
9. Cantagrel V., Lefeber D.J., Ng B.G., Guan Z., Silhavy J.L., Bielas S.L., Lehle L., Hombauer H., Adamowicz M., Swiezewska E., De Brouwer A.P., Blümel P., Sykut-Cegielska J., Houliston S., Swistun D., Ali B.R., Dobyns W.B., Babovic-Vuksanovic D., van Bokhoven H., Wevers R.A., Raetz C.R., Freeze H.H., Morava E., Al-Gazali L., Gleeson J.G. SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell 2010, 142:203-217.
10. Castro B., Sánchez P., Torres J.M., Preda O., del Moral R.G., Ortega E. Bisphenol A exposure during adulthood alters expression of aromatase and 5α-reductase isozymes in rat prostate. PLoS One 2013, 8:e55905.
11. Castro B., Sánchez P., Torres J.M., Ortega E. Effects of adult exposure to bisphenol A on genes involved in the physiopathology of rat prefrontal cortex. PLoS One 2013, 8:e73584.
12. Castro B., Sánchez P., Miranda M.T., Torres J.M., Ortega E. Identification of dopamine- and serotonin- related genes modulated by bisphenol A in the prefrontal cortex of male rats. Chemosphere 2015, 139:235-239.
13. Celotti F., Negri-Cesi P., Poletti A. Steroid metabolism in the mammalian brain: 5alpha-reduction and aromatization. Brain Res. Bull. 1997, 44:365-375.
14. Clarke H.F., Dalley J.W., Crofts H.S., Robbins T.W., Roberts A.C. Cognitive inflexibility after prefrontal serotonin depletion. Science 2004, 304:878-880.
15. Cools R., Stefanova E., Barker R.A., Robbins T.W., Owen A.M. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 2002, 125:584-594.
16. Davidson R.J. Anxiety and affective style: role of prefrontal cortex and amygdala. Biol. Psychiatry 2002, 51:68-80.
17. Finn D.A., Beadles-Bohling A.S., Beckley E.H., Ford M.M., Gililland K.R., Gorin-Meyer R.E., Wiren K.M. A new look at the 5alpha-reductase inhibitor finasteride. CNS Drug Rev. 2006, 12:53-76.
18. Fritschy J.M., Panzanelli P. GABAA receptors and plasticity of inhibitory neurotransmission in the central nervous system. Eur. J. Neurosci. 2014, 39:1845-1865.
19. Fronhoffs S., Totzke G., Stier S., Wernert N., Rothe M., Brüning T., Koch B., Sachinidis A., Vetter H., Ko Y. A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction. Mol. Cell. Probes 2002, 16:99-110.
20. Frye C.A. Neurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functions. Psychoneuroendocrinology 2009, 34:S143-S161.
21. Frye C.A., Bo E., Calamandrei G., Calzà L., Dessì-Fulgheri F., Fernández M., Fusani L., Kah O., Kajta M., Le Page Y., Patisaul H.B., Venerosi A., Wojtowicz A.K., Panzica G.C. Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behaviour and neuroendocrine systems. J. Neuroendocrinol. 2012, 24:144-159.
22. Ghosh A., Carnahan J., Greenberg M.E. Requirement for BDNF in activity-dependent survival of cortical neurons. Science 1994, 263:1618-1623.
23. Goldman-Rakic P.S., Muly E.C., Williams G.V. D(1) receptors in prefrontal cells and circuits. Brain Res. Rev. 2000, 31:295-301.
24. Haduch A., Bromek E., Sadakierska-Chudy A., Wójcikowski J., Daniel W.A. The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5-methoxytryptamine in the brain: an in vitro study. Pharmacol. Res. 2013, 67:53-59.
25. Harley K.G., Gunier R.B., Kogut K., Johnson C., Bradman A., Calafat A.M., Eskenazi B. Prenatal and early childhood bisphenol A concentrations and behavior in school-aged children. Environ. Res. 2013, 126:43-50.
26. Hiroi T., Imaoka S., Chow T., Funae Y. Tissue distributions of CYP2D1, 2D2, 2D3 and 2D4 mRNA in rats detected by RT-PCR. Biochim. Biophys. Acta 1998, 1380:305-312.
27. Honma T., Miyagawa M., Suda M., Wang R.S., Kobayashi K., Sekiguchi S. Effects of perinatal exposure to bisphenol A on brain neurotransmitters in female rat offspring. Ind. Health 2006, 44:510-524.
28. Jang Y.J., Park H.R., Kim T.H., Yang W.J., Lee J.J., Choi S.Y., Oh S.B., Lee E., Park J.H., Kim H.P., Kim H.S., Lee J. High dose bisphenol A impairs hippocampal neurogenesis in female mice across generations. Toxicology 2012, 296:73-82.
29. Kalbitzer J., Deserno L., Schlagenhauf F., Beck A., Mell T., Bahr G., Buchholz H.G., Plotkin M., Buchert R., Kumakura Y., Cumming P., Heinz A., Rapp M.A. Decline in prefrontal catecholamine synthesis explains age-related changes in cognitive speed beyond regional grey matter atrophy. Eur. J. Nucl. Med. Mol. Imaging 2012, 39:1462-1466.
30. Kinch C.D., Ibhazehiebo K., Jeong J.H., Habibi H.R., Kurrasch D.M. Low-dose exposure to bisphenol A and replacement bisphenol S induces precocious hypothalamic neurogenesis in embryonic zebrafish. Proc. Natl. Acad. Sci. USA 2015, 112:1475-1480.
31. Kishimoto W., Hiroi T., Shiraishi M., Osada M., Imaoka S., Kominami S., Igarashi T., Funae Y. Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brain. Endocrinology 2004, 145:699-705.
32. Lee H.J., Chattopadhyay S., Gong E.Y., Ahn R.S., Lee K. Antiandrogenic effects of bisphenol A and nonylphenol on the function of androgen receptor. Toxicol. Sci. 2003, 75:40-46.
33. Liao C., Liu F., Moon H.B., Yamashita N., Yun S., Kannan K. Bisphenol analogues in sediments from industrialized areas in the United States. Environ. Sci. Technol. 2012, 46:11558-11565.
34. Liao C., Kannan K. Concentrations and profiles of bisphenol A and other bisphenol analogues in foodstuffs from the United States and their implications for human exposure. J. Agric. Food Chem. 2013, 61:4655-4662.
35. Liao C., Liu F., Kannan K. Bisphenol s, a new bisphenol analogue, in paper products and currency bills and its association with bisphenol a residues. Environ. Sci. Technol. 2012, 46:6515-6522.
36. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408.
37. Matsuda S., Matsuzawa D., Ishii D., Tomizawa H., Sajiki J., Shimizu E. Perinatal exposure to bisphenol A enhances contextual fear memory and affects the serotoninergic system in juvenile female mice. Horm. Behav. 2013, 63:709-716.
38. Matsuda S., Matsuzawa D., Ishii D., Tomizawa H., Sutoh C., Nakazawa K., Amano K., Sajiki J., Shimizu E. Effects of perinatal exposure to low dose of bisphenol A on anxiety like behavior and dopamine metabolites in brain. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 39:273-279.
39. Miller C.L., Llenos I.C., Dulay J.R., Barillo M.M., Yolken R.H., Weis S. Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. Neurobiol. Dis. 2004, 15:618-629.
40. Milward E.A., Papadopoulos R., Fuller S.J., Moir R.D., Small D., Beyreuther K., Masters C.L. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 1992, 9:129-137.
41. Narita M., Miyagawa K., Mizuo K., Yoshida T., Suzuki T. Prenatal and neonatal exposure to low-dose of bisphenol-A enhance the morphine-induced hyperlocomotion and rewarding effect. Neurosci. Lett. 2006, 402:249-252.
42. Palanza P., Gioiosa L., vom Saal F.S., Parmigiani S. Effects of developmental exposure to bisphenol A on brain and behavior in mice. Environ. Res. 2008, 108:150-157.
43. Paris J.J., Brunton P.J., Russell J.A., Frye C.A. Immune stress in late pregnant rats decreases length of gestation and fecundity, and alters later cognitive and affective behaviour of surviving pre-adolescent offspring. Stress 2011, 14:652-664.
44. Paris J.J., Walf A.A., Frye C.A. II. Cognitive performance of middle-aged female rats is influenced by capacity to metabolize progesterone in the prefrontal cortex and hippocampus. Brain Res. 2011, 1379:149-163.
45. Perera F., Vishnevetsky J., Herbstman J.B., Calafat A.M., Xiong W., Rauh V., Wang S. Prenatal bisphenol A exposure and child behavior in an inner-city cohort. Environ. Health Perspect. 2012, 120:1190-1194.
46. Perez R.G., Zheng H., Van der Ploeg L.H., Koo E.H. The beta-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity. J. Neurosci. 1997, 17:9407-9414.
47. Poletti A., Coscarella A., Negri-Cesi P., Colciago A., Celotti F., Martini L. 5 alpha-reductase isozymes in the central nervous system. Steroids 1998, 63:246-251.
48. Prins G.S., Ye S.H., Birch L., Ho S.M., Kannan K. Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats. Reprod. Toxicol. 2011, 31:1-9.
49. Roen E.L., Wang Y., Calafat A.M., Wang S., Margolis A., Herbstman J., Hoepner L.A., Rauh V., Perera F.P. Bisphenol A exposure and behavioral problems among inner city children at 7-9 years of age. Environ. Res. 2015, 10.1016/j.envres.2015.01.014.
50. Sánchez P., Castro B., Torres J.M., Olmo A., Del Moral R.G., Ortega E. Bisphenol A modifies the regulation exerted by testosterone on 5α-reductase isozymes in ventral prostate of adult rats. Biomed. Res. Int. 2013, 2013:629235.
51. Sánchez P., Torres J.M., Ortega E. Effects of dihydrotestosterone on brain mRNA levels of steroid 5alpha-reductase isozymes in early postnatal life of rat. Neurochem. Res. 2005, 30:577-581.
52. Simoneau C., Valzacchi S., Morkunas V., Van den Eede L. Comparison of migration from polyethersulphone and polycarbonate baby bottles. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2011, 28:1763-1768.
53. Taylor J.A., Welshons W.V., Vom Saal F.S. No effect of route of exposure (oral; subcutaneous injection) on plasma bisphenol A throughout 24h after administration in neonatal female mice. Reprod. Toxicol. 2008, 25:169-176.
54. Torres J.M., Ortega E. Steroid 5α-reductase isozymes in the adult female rat brain: central role of dihydrotestosterone. J. Mol. Endocrinol. 2006, 36:239-245.
55. Taves M.D., Gomez-Sanchez C.E., Soma K.K. Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function. Am. J. Physiol. Endocrinol. Metab. 2011, 301:11-24.
56. Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R., Lee D.H., Shioda T., Soto A.M., vom Saal F.S., Welshons W.V., Zoeller R.T., Myers J.P. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr. Rev. 2012, 33:378-455.
57. Vitalis T., Ansorge M.S., Dayer A.G. Serotonin homeostasis and serotonin receptors as actors of cortical construction: special attention to the 5-HT3A and 5-HT6 receptor subtypes. Front. Cell. Neurosci. 2013, 7:93.
58. Warita K., Mitsuhashi T., Ohta K., Suzuki S., Hoshi N., Miki T., Takeuchi Y. In vitro evaluation of gene expression changes for gonadotropin-releasing hormone 1, brain-derived neurotrophic factor and neurotrophic tyrosine kinase, receptor, type 2, in response to bisphenol A treatment. Congenit. Anom. 2013, 53:42-45.
59. Welshons W.V., Nagel S.C., vom Saal F.S. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 2006, 147:S56-S69.
60. Wolstenholme J.T., Rissman E.F., Connelly J.J. The role of bisphenol A in shaping the brain, epigenome and behavior. Horm. Behav. 2011, 59:296-305.